Skip to main content
SpringerLink
Log in

Antibiotic Policies in the Intensive Care Unit

  • Chapter
Book cover Infection Control in the Intensive Care Unit

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vollaard EJ, Clasener HAL (1994) Colonisation resistance. Antimicrob Agents Chemother 335:409–414

    Google Scholar 

  2. Vlaspolder F, Zeeuw G de, Rozenberg-Arska M et al (1987) The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract. Infection 15:241–244

    Article  PubMed  CAS  Google Scholar 

  3. Harbarth S, Liassine N, Dharan S et al (2000) Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 31:1380–1385

    Article  PubMed  CAS  Google Scholar 

  4. Shek FW, Stacey BSF, Rendell J et al (2000) The rise of Clostridium difficile: the effect of length of stay, patient age and antibiotic use. J Hosp Infect 45:235–237

    Article  PubMed  CAS  Google Scholar 

  5. Donskey CJ, Chowdry TK, Hecker MT et al (2000) Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonised patients. N Engl J Med 343:1925–1932

    Article  PubMed  CAS  Google Scholar 

  6. van Saene R, Fairclough S, Petros A (1998) Broad-and narrow-spectrum antibiotics: a different approach. Clin Microbiol Infect 4:56–57

    PubMed  Google Scholar 

  7. Buck AC, Cooke EM (1969) The fate of ingested Pseudomonas aeruginosa in normal persons. J Med Microbiol 2:521–525

    PubMed  CAS  Google Scholar 

  8. van Saene HKF, Stoutenbeek CP, Geitz JN et al (1988) Effect of amoxycillin on colonisation resistance in human volunteers.Microb Ecol Health Dis 1:169–177

    Article  Google Scholar 

  9. Vollaard EJ, Clasener HAL, Janssen AJHM et al (1990) Influence of amoxycillin on microbial colonisation resistance in healthy volunteers. A methodological study. J Antimicrob Chemother 25:861–871

    PubMed  CAS  Google Scholar 

  10. Vollaard EJ, Clasener HAL, Janssen AJHM et al (1990) Influence of cefotaxime on microbial colonisation resistance in healthy volunteers. J Antimicrob Chemother 26:117–123

    PubMed  CAS  Google Scholar 

  11. Vollaard EJ, Clasener HAL, Janssen AJHM (1992) Influence of cephradine on microbial colonisation resistance in healthy volunteers.Microb Ecol Health Dis 5:147–153

    Google Scholar 

  12. Toltzis P, Yamashita T, Vilt L et al (1998) Antibiotic restriction does not alter endemic colonisation with resistant Gram-negative rods in a pediatric intensive care unit. Crit Care Med 26:1893–1899

    PubMed  CAS  Google Scholar 

  13. Samonis G, Gikas A, Toloudis P et al (1994) Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur J Clin Microbiol Infect Dis 13:665–667

    Article  PubMed  CAS  Google Scholar 

  14. Krcmery V Jr, Oravcova E, Spanik S et al (1998) Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical anti-fungal therapy in 41 cancer patients receiving anti-neoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 41:373–380.

    Article  PubMed  CAS  Google Scholar 

  15. Lode H, von der Höh N, Ziege S et al (2001)Ecological effects of linezolid versus amoxicillin/ clavulanic acid on the normal intestinal microflora. Scand J Infect Dis 33:899–903.

    Article  PubMed  CAS  Google Scholar 

  16. Cunha AC (2001) Effective antibiotic-resistance control strategies. Lancet 357:1307–1308

    Article  PubMed  CAS  Google Scholar 

  17. Lee SC, Fung CP, Liu PYF et al (1999) Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. Infect Control Hosp Epidemiol 20:205–207

    Article  PubMed  CAS  Google Scholar 

  18. Fink MP, Snydman DR, Niederman MS et al (1994) Treatment of severe pneumonia in hospitalised patients: results of a multi-center, randomised, double-blind trial comparing intravenous ciprofloxacin and imipenem-cilastatin. Antimicrob Agents Chemother 38:547–557

    PubMed  CAS  Google Scholar 

  19. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43: 1379–1382

    PubMed  CAS  Google Scholar 

  20. Lacey RW, Lord VL, Howson GL et al (1983) Double-blind study to compare the selection of antibiotic resistance by amoxycillin or cephradine in the commensal flora. Lancet II:529–532

    Article  Google Scholar 

  21. de Man P, Verhoeven BAN, Verburgh HA et al (2000) An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355:973–978

    Article  PubMed  Google Scholar 

  22. Cunha BA (2000) Antibiotic resistance.Med Clin North Am 84:1407–1429

    Article  PubMed  CAS  Google Scholar 

  23. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance.Antimicrob Agents Chemother 43:727–737

    PubMed  CAS  Google Scholar 

  24. Gerding DN, Larson TA, Hughes RA et al (1991) Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35:1284–1290

    PubMed  CAS  Google Scholar 

  25. Toltzis P, Dul M, O’Riordan MA et al (2003) Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli. Pediatr Infect Dis J 22:109–114

    Article  PubMed  Google Scholar 

  26. Gillespie T, Masterton RG (2002) Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients. Int J Antimicrob Agents 19:377–382

    Article  PubMed  CAS  Google Scholar 

  27. Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634–640

    Article  PubMed  CAS  Google Scholar 

  28. Dofferhoff AS, Nijland JH, de Vries-Hospers HG et al (1991) Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in vitro and in vivo study. Scand J Infect Dis 23:745–754

    PubMed  CAS  Google Scholar 

  29. Jackson JJ, Kropp H (1992) Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 165:1033–1041

    PubMed  CAS  Google Scholar 

  30. Prins JM, van Deventer SJH, Kuijper EJ, Speelman P (1994) Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 38:1211–1218

    PubMed  CAS  Google Scholar 

  31. Luchi M, Morrison DC, Opal S et al (2000) A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis. J Endotoxin Res 6:25–31

    PubMed  CAS  Google Scholar 

  32. Prins JM, van Agtmael MA, Kuijper EJ et al (1995) Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 172:888–891

    Google Scholar 

  33. Holzheimer RG, Hirte JF, Reith B et al (1996) Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J Endotoxin Res 3:261–267

    CAS  Google Scholar 

  34. Crosby HA, Bion JF, Penn CW, Elliott TSJ (1994) Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol 40:23–30

    Article  PubMed  CAS  Google Scholar 

  35. Artenstein AW, Cross AS (1989) Inhibition of endotoxin reactivity by aminoglycosides. J Antimicrob Chemother 24:826–828

    PubMed  CAS  Google Scholar 

  36. Foca A, Matera G, Berlinghieri MC (1993) Inhibition of endotoxin-induced interleukin 8 release by teicoplanin in human whole blood. Eur J Clin Microbiol Infect Dis 12:940–944

    Article  PubMed  CAS  Google Scholar 

  37. Siedlar M, Szczepanik A, Wieckiewicz J et al (1997) Vancomycin down-regulates lipopolysaccharide-induced tumour necrosis factor alpha (TNF alpha) and TNF alpha mRNA accumulation in human blood monocytes. Immunopharmacology 35:265–271

    Article  PubMed  CAS  Google Scholar 

  38. Prentice HG, Hann IM, Herbrecht R et al (1997) A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 98:711–718

    Article  PubMed  CAS  Google Scholar 

  39. Peters M, Petros A, Dixon G et al (1999) Acquired immuno-paralysis in paediatric intensive care: prospective observational study. BMJ 319:609–610

    PubMed  CAS  Google Scholar 

  40. Kaiser AB (1986) Antimicrobial prophylaxis in surgery. N Engl J Med 315:1129–1138

    Article  PubMed  CAS  Google Scholar 

  41. Stoutenbeek CP (1989) The role of systemic antibiotic prophylaxis in infection prevention in intensive care by SDD. Infection 17:418–421

    Article  PubMed  CAS  Google Scholar 

  42. Lingnau W, Berger J, Javorsky F et al (1997) Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 42:687–694

    Article  PubMed  CAS  Google Scholar 

  43. Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomised, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 25:63–71

    Article  PubMed  CAS  Google Scholar 

  44. Krueger WA, Lenhart FP, Neeser G et al (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill patients. Am J Respir Crit Care Med 166:1029–1037

    Article  PubMed  Google Scholar 

  45. Baxby D, van Saene HKF, Stoutenbeek CP, Zandstra DF (1996) Selective decontamination of the digestive tract: 13 years on,what it is and what it is not. Intensive Care Med 22:699–706

    PubMed  CAS  Google Scholar 

  46. Damjanovic V, Connolly CM, van Saene HKF et al (1993) Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24:245–259

    Article  PubMed  CAS  Google Scholar 

  47. Cal MA de la, Cerda E, van Saene HKF et al (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56:175–183

    Article  PubMed  Google Scholar 

  48. Desai MH, Rutan RL, Heggers JP, Herndon DN (1992) Candida infection with and without nystatin prophylaxis. Arch Surg 127: 159–162

    PubMed  CAS  Google Scholar 

  49. Morar P, Makura Z, Jones A et al (2000) Topical antibiotics on tracheostoma prevents exogenous colonisation and infection of lower airways in children. Chest 117:513–518

    Article  PubMed  CAS  Google Scholar 

  50. Alcock SR (1990) Short-term parenteral antibiotics used as a supplement to SDD regimens. Infection 13[Suppl 1]:S14–S18

    Article  Google Scholar 

  51. Sirvent JM, Torres A, El-Ebiary M et al (1997) Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 155:1729–1734

    PubMed  CAS  Google Scholar 

  52. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies (1995). A consensus statement. Am J Respir Crit Care Med 153:1711–1725

    Google Scholar 

  53. Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. A randomised trial. JAMA 290: 2588–2598

    CAS  Google Scholar 

  54. A’Court CHD, Garrard CS, Crook D et al (1993) Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Q J Med 86:635–648

    PubMed  CAS  Google Scholar 

  55. Montravers P, Fagon JY, Chastre J et al (1993) Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 147:38–44

    PubMed  CAS  Google Scholar 

  56. Singh N, Rogers P, Atwood CW et al (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am J Respir Crit Care Med 162:505–511

    PubMed  CAS  Google Scholar 

  57. Dennesen PJW, van derVen AJAM, Kessels AGH et al (2001) Resolution of infectious parameters after antimicrobial therapy in patients with VAP. Am J Respir Crit Care Med 163:1371–1375

    PubMed  CAS  Google Scholar 

  58. Ibrahim EH, Ward S, Sherman G et al (2001) Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29:1109–1115

    Article  PubMed  CAS  Google Scholar 

  59. Condon RE (2002) Bacterial resistance to antibiotics. Arch Surg 137:1417–1418

    Article  PubMed  Google Scholar 

  60. Torres A, Ewig S (2004) Diagnosing ventilator-associated pneumonia. N Engl J Med 350:433–435.

    Article  PubMed  CAS  Google Scholar 

  61. Ledingham I McA, Alcock SR, Eastaway AT et al (1988) Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet I:785–790

    Article  Google Scholar 

  62. Luna CM, Vujacich P, Niederman MS et al (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685

    PubMed  CAS  Google Scholar 

  63. Alvarez-Lerma F and the ICU-acquired Pneumonia Study Group (1996) Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 22:387–394

    Article  PubMed  CAS  Google Scholar 

  64. Sarginson RE, Taylor N, Reilly N et al (2004) Infection in prolonged pediatric critical illness: a prospective four year study based on knowledge of the carrier state. Crit Care Med 32: 839–847

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology, University of Liverpool, Alder Hey Children’s Hospital, NHS Trust, Liverpool, UK

    H.K.F. van Saene

  2. Department of Pharmacy, Alder Hey Children’s Hospital, Liverpool, UK

    N.J. Reilly

  3. Department of Anaesthesia and Intensive Care, University Hospital of S. Maria della Misericordia, Udine, Italy

    A. de Silvestre

  4. Department of Anesthesia and Intensive Care, University Hospital of S. Camillo Forlanini, Rome, Italy

    G. Nardi

Authors
  1. H.K.F. van Saene
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N.J. Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. de Silvestre
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Nardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, University of Liverpool Alder Hey Children’s Hospital, NHS Trust, Liverpool, UK

    H. K. F. van Saene M.D.

  2. Department of Critical Care Medicine, University Hospital of Getafe, Madrid, Spain

    M. A. De La Cal M.D.

  3. Emergency Department and Unit of Anesthesia and Intensive Care, Presidio Ospedaliero of Gorizia, Gorizia, Italy

    L. Silvestri M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Italia

About this chapter

Cite this chapter

van Saene, H., Reilly, N., de Silvestre, A., Nardi, G. (2005). Antibiotic Policies in the Intensive Care Unit. In: van Saene, H.K.F., De La Cal, M.A., Silvestri, L. (eds) Infection Control in the Intensive Care Unit. Topics in Anaesthesia and Critical Care. Springer, Milano . https://doi.org/10.1007/88-470-0361-X_12

Download citation

  • DOI: https://doi.org/10.1007/88-470-0361-X_12

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0185-5

  • Online ISBN: 978-88-470-0361-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation